Esplanade Ventures
VC Fund
Montréal, Canada
Esplanade Ventures is a VC fund in Montréal focused on Health Care and Artificial Intelligence. Esplanade focuses on early stage and high-growth companies within digital health and primarily invest in Seed and Series A companies, with a geographic focus on North America, Israel and Europe. Our team is composed of healthcare practitioners, operators and founders. Esplanade empowers innovative digital health companies by supplementing capitalwith active strategic direction, business development and distribution channel support.
- Total investments:
- 16
- Last investment:
- Lead investor:
- 44%
- Fund size:
- $15M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Esplanade Ventures invests in
Stages Esplanade Ventures invests in
Countries Esplanade Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Ella Seitz
|
|||
Alexandre Nossovskoi
|
|||
Daniel Warner
|
|||
Jeffrey Kadanoff
|
|||
Josh Blair
|
Investment Focus
Industry
- Health Care 3 (19%)
- Artificial Intelligence 3 (19%)
- Software 2 (13%)
- Personal Health 2 (13%)
- Information Technology 2 (13%)
Stage
- Seed 3 (19%)
- Series A 2 (13%)
- Series B 1 (6%)
Country
- Canada 3 (19%)
- Israel 1 (6%)
- United States 1 (6%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Ella Seitz
Partner
|
Partner | Total investments: 3 | Find email | |
|
Alexandre Nossovskoi
Principal
|
Principal | Total investments: 0 | Find email | |
|
Daniel Warner
Entrepreneur In Residence
|
Entrepreneur In Residence | Total investments: 0 | Find email | |
|
Jeffrey Kadanoff
Managing Director
|
Managing Director | Total investments: 0 | Find email | |
|
Josh Blair
Partner
|
Partner | Total investments: 0 | Find email | |
| See all 6 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
QuantHealth
|
Quant Health offers drug simulation, computational biology, clinical data science, respiratory, trial simulation, and oncology services. | $45M / Series B / Aug 04, 2026 | |
Osteoboost
|
Bone Health Technologies specializes in developing medical devices designed for low bone mass. Its solution is a gentle mechanical stimulation that mimics weight-bearing exercise, providing an effective non-drug intervention. It offers the OsteoBoost device that relies on safe, natural, and effective whole-body vibration technology usingvibrational energy to turn stem cells into the bone using the same mechanisms as physical exercise. The company was founded in 2018 and is headquartered in San Francisco, California. | $8M / Series A / Apr 09, 2026 | |
No Barrier
|
$2.7M / Seed / Nov 17, 2025 | ||
Neura Health
|
Neura Health is a venture-backed startup with a mission to improve access and quality of care for neurologic conditions. Our longer-term vision is to find cures by learning from the experience of every neurology patient. We were inspired to create Neura because of two key problems in neurology: access and quality. Access is sub-par because thereare not enough neurologists in the country, so the average wait time is 35 days, with patients often having to travel hours to access the right specialist. Quality is sub-par because diagnoses are currently based on self-reported data with significant recency bias. | $11.4M / Series A / Sep 29, 2025 | |
Cerula Care
|
Cerula Care specializes in behavioral health services for people with chronic conditions. | $5.5M / Seed / Feb 12, 2025 | |
Rad AI
|
Rad AI develops an artificial intelligence automated report generation platform to automate repetitive tasks for radiologists. Its platform integrates with existing workflow, automating repetitive tasks, and enabling radiologists to improve radiology workflow that maximizes efficiency and accuracy while reducing burnout for radiologists andimproving patient care. | $50M / Series B / May 07, 2024 | |
Tali AI
|
Tali AI is an impact-oriented company that provides physicians with a voice-enabled virtual assistant that is placed over their electronic health records. The system dictates notes directly into the EHR to add information about patients and drugs. The company's contact mode is at its physical address. | Seed / Nov 08, 2023 | |
Override
|
With Override, we pair each patient with a virtual, interdisciplinary care team that really discusses how to help patients improve and overcome hurdles to advancement. | $1M / Seed / Aug 16, 2023 | |
Babbly
|
Babbly is building the world's largest data platform to help parents monitor and support their child's development. Our first product is a mobile app that lets parents track their baby's speech development using a video recording of their child. | $2.5M / Seed / Jun 10, 2022 | |
BrainBox AI
|
BrainBox AI utilizes cloud-based computing, algorithms, and a proprietary process to create an autonomous building technology. The company's solution supports 24/7 self-operating building that enables maximum energy efficiency and reduces cost. BrainBox AI was founded in 2017 and is headquartered in Montréal, Quebec, Canada. | $24M / Series A / Oct 28, 2021 | |
| See all 16 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Esplanade Ventures invest in?
Esplanade Ventures invests primarily in Health Care, Artificial Intelligence and Software startups, most often at Seed and Series A stage. Most of the 16 investments tracked by Shizune back companies in Canada. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Esplanade Ventures?
Public channels for Esplanade Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Esplanade Ventures?
The team at Esplanade Ventures includes Ella Seitz (Partner), Alexandre Nossovskoi (Principal) and Daniel Warner (Entrepreneur In Residence), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
